ReviewFrontiers in medicine2026
Comprehensive management of ischemic stroke with traditional Chinese medicine: a new exploration.
Review in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Early Integration of Chinese Medicine Rehabilitation Improves Functional Outcomes in Stroke Patients: A Prospective Pragmatic Study and Nested Case-Control Analysis.CNS neuroscience & therapeutics · 2026Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ischemic stroke exhibits considerable variability across regions, age groups, sexes, and ethnicities, with risk factors encompassing genetic, environmental, and socioeconomic dimensions. Its pathophysiology is multifaceted and involves disturbances in energy metabolism, disruption of the BBB, and inflammatory processes, among other mechanisms. Diagnostic advancements including imaging modalities, biomarker identification, and artificial intelligence applications have significantly enhanced clinical practice. Therapeutic strategies primarily focus on reperfusion and antiplatelet therapies, while traditional Chinese medicine (TCM) demonstrates potential through multi-targeted and multi-modal approaches. Rehabilitation and prevention efforts underscore the importance of multidisciplinary collaboration, personalized treatment plans, and early risk factor interventions. Rooted in the traditional conceptualization of stroke, TCM exerts its effects via anti-inflammatory, antioxidant, and metabolic regulatory pathways, and has shown promising clinical outcomes when integrated with conventional medicine. Nonetheless, challenges remain regarding the robustness of the efficacy evidence, standardization of syndrome differentiation, and safety concerns. Future directions point toward the integration of multi-omics technologies, artificial intelligence, precision medicine, and international collaboration to advance the comprehensive management of ischemic stroke by incorporating TCM.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.